Novel BCL6 Inhibitor (FX1): Advances in Diffuse Large B-Cell Lymphomas (DLBCLs) Treatment
Biomedical Sciences
doi 10.11648/j.bs.20170302.12
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Science Publishing Group